191 related articles for article (PubMed ID: 30131519)
1. A FTIR microspectroscopy study of the structural and biochemical perturbations induced by natively folded and aggregated transthyretin in HL-1 cardiomyocytes.
Ami D; Mereghetti P; Leri M; Giorgetti S; Natalello A; Doglia SM; Stefani M; Bucciantini M
Sci Rep; 2018 Aug; 8(1):12508. PubMed ID: 30131519
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.
Sartiani L; Bucciantini M; Spinelli V; Leri M; Natalello A; Nosi D; Maria Doglia S; Relini A; Penco A; Giorgetti S; Gerace E; Mannaioni G; Bellotti V; Rigacci S; Cerbai E; Stefani M
Biophys J; 2016 Nov; 111(9):2024-2038. PubMed ID: 27806283
[TBL] [Abstract][Full Text] [Related]
3. Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.
Ferrão-Gonzales AD; Palmieri L; Valory M; Silva JL; Lashuel H; Kelly JW; Foguel D
J Mol Biol; 2003 May; 328(4):963-74. PubMed ID: 12729768
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
Lashuel HA; Lai Z; Kelly JW
Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152
[TBL] [Abstract][Full Text] [Related]
5. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.
Rodrigues JR; Simões CJ; Silva CG; Brito RM
Protein Sci; 2010 Feb; 19(2):202-19. PubMed ID: 19937650
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.
Lim KH; Dasari AKR; Ma R; Hung I; Gan Z; Kelly JW; Fitzgerald MC
Biochemistry; 2017 Sep; 56(36):4808-4818. PubMed ID: 28820582
[TBL] [Abstract][Full Text] [Related]
7. S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset.
Leri M; Rebuzzini P; Caselli A; Luti S; Natalello A; Giorgetti S; Marchese L; Garagna S; Stefani M; Paoli P; Bucciantini M
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129453. PubMed ID: 31676294
[TBL] [Abstract][Full Text] [Related]
8. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.
Lashuel HA; Wurth C; Woo L; Kelly JW
Biochemistry; 1999 Oct; 38(41):13560-73. PubMed ID: 10521263
[TBL] [Abstract][Full Text] [Related]
9. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
[TBL] [Abstract][Full Text] [Related]
10. The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies.
Leri M; Nosi D; Natalello A; Porcari R; Ramazzotti M; Chiti F; Bellotti V; Doglia SM; Stefani M; Bucciantini M
J Nutr Biochem; 2016 Apr; 30():153-66. PubMed ID: 27012632
[TBL] [Abstract][Full Text] [Related]
11. Cooperative stabilization of transthyretin by clusterin and diflunisal.
Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
[TBL] [Abstract][Full Text] [Related]
12. Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.
Dasari AKR; Hung I; Gan Z; Lim KH
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):344-349. PubMed ID: 30366153
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
[TBL] [Abstract][Full Text] [Related]
14. FRET studies of various conformational states adopted by transthyretin.
Ghadami SA; Bemporad F; Sala BM; Tiana G; Ricagno S; Chiti F
Cell Mol Life Sci; 2017 Oct; 74(19):3577-3598. PubMed ID: 28478513
[TBL] [Abstract][Full Text] [Related]
15. Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
Higaki JN; Chakrabartty A; Galant NJ; Hadley KC; Hammerson B; Nijjar T; Torres R; Tapia JR; Salmans J; Barbour R; Tam SJ; Flanagan K; Zago W; Kinney GG
Amyloid; 2016 Jun; 23(2):86-97. PubMed ID: 26981744
[TBL] [Abstract][Full Text] [Related]
16. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution.
Quintas A; Saraiva MJ; Brito RM
FEBS Lett; 1997 Dec; 418(3):297-300. PubMed ID: 9428731
[TBL] [Abstract][Full Text] [Related]
17. Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers.
Yang M; Lei M; Huo S
Protein Sci; 2003 Jun; 12(6):1222-31. PubMed ID: 12761393
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
[TBL] [Abstract][Full Text] [Related]
19. NMR Measurements Reveal the Structural Basis of Transthyretin Destabilization by Pathogenic Mutations.
Leach BI; Zhang X; Kelly JW; Dyson HJ; Wright PE
Biochemistry; 2018 Jul; 57(30):4421-4430. PubMed ID: 29972637
[TBL] [Abstract][Full Text] [Related]
20. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
